Latest Insider Transactions at Bristol Myers Squibb CO (BMY)
This section provides a real-time view of insider transactions for Bristol Myers Squibb CO (BMY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BRISTOL MYERS SQUIBB CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BRISTOL MYERS SQUIBB CO's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2021
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
4,189
+31.57%
|
-
|
|
Mar 10
2021
|
David V Elkins EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,329
-4.74%
|
$259,740
$60.93 P/Share
|
|
Mar 10
2021
|
David V Elkins EVP, Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
150
+0.16%
|
-
|
|
Mar 10
2021
|
David V Elkins EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,025
+8.09%
|
-
|
|
Mar 10
2021
|
Joseph Eid SVP,Head Glob. Medical Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
2,192
-6.72%
|
$131,520
$60.93 P/Share
|
|
Mar 10
2021
|
Joseph Eid SVP,Head Glob. Medical Affairs |
BUY
Other acquisition or disposition
|
Direct |
909
+3.13%
|
-
|
|
Mar 10
2021
|
Joseph Eid SVP,Head Glob. Medical Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
6,134
+16.03%
|
-
|
|
Mar 10
2021
|
Joseph Eid SVP,Head Glob. Medical Affairs |
SELL
Other acquisition or disposition
|
Direct |
55
-1.1%
|
-
|
|
Mar 10
2021
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,910
-2.08%
|
$114,600
$60.93 P/Share
|
|
Mar 10
2021
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
BUY
Other acquisition or disposition
|
Direct |
718
+0.93%
|
-
|
|
Mar 10
2021
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
BUY
Exercise of conversion of derivative security
|
Direct |
5,404
+5.55%
|
-
|
|
Mar 10
2021
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
SELL
Other acquisition or disposition
|
Direct |
36
-0.23%
|
-
|
|
Mar 10
2021
|
Christopher S. Boerner Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,851
-7.47%
|
$771,060
$60.93 P/Share
|
|
Mar 10
2021
|
Christopher S. Boerner Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
2,643
+1.78%
|
-
|
|
Mar 10
2021
|
Christopher S. Boerner Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,215
+12.77%
|
-
|
|
Mar 10
2021
|
Christopher S. Boerner Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
154
-0.61%
|
-
|
|
Mar 10
2021
|
Giovanni Caforio Executive Chair of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
112,233
-4.04%
|
$6,733,980
$60.93 P/Share
|
|
Mar 10
2021
|
Giovanni Caforio Executive Chair of the Board |
BUY
Other acquisition or disposition
|
Direct |
22,035
+0.94%
|
-
|
|
Mar 10
2021
|
Giovanni Caforio Executive Chair of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
200,709
+6.63%
|
-
|
|
Mar 10
2021
|
Giovanni Caforio Executive Chair of the Board |
SELL
Other acquisition or disposition
|
Direct |
1,635
-0.34%
|
-
|
|
Mar 01
2021
|
Rupert Vessey EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct |
8,944
-11.1%
|
$545,584
$61.63 P/Share
|
|
Mar 01
2021
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
23,349
+22.47%
|
-
|
|
Mar 01
2021
|
David V Elkins EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,573
-9.34%
|
$522,953
$61.63 P/Share
|
|
Mar 01
2021
|
David V Elkins EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,579
+21.13%
|
-
|
|
Feb 04
2021
|
Rupert Vessey EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct |
1,186
-2.03%
|
$72,346
$61.56 P/Share
|
|
Feb 04
2021
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
3,592
+5.79%
|
-
|
|
Dec 31
2020
|
Nadim Ahmed EVP and President, Hematology |
SELL
Payment of exercise price or tax liability
|
Direct |
7,660
-16.46%
|
$474,920
$62.03 P/Share
|
|
Dec 31
2020
|
Nadim Ahmed EVP and President, Hematology |
BUY
Exercise of conversion of derivative security
|
Direct |
14,946
+24.3%
|
-
|
|
Dec 31
2020
|
David V Elkins EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,931
-15.08%
|
$739,722
$62.03 P/Share
|
|
Dec 31
2020
|
David V Elkins EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,624
+20.68%
|
-
|
|
Dec 31
2020
|
Rupert Vessey EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct |
13,257
-19.47%
|
$821,934
$62.03 P/Share
|
|
Dec 31
2020
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
25,866
+27.53%
|
-
|
|
Dec 02
2020
|
Christopher S. Boerner Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,299
-5.49%
|
$80,538
$62.18 P/Share
|
|
Dec 02
2020
|
Christopher S. Boerner Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,637
+10.02%
|
-
|
|
Dec 02
2020
|
David V Elkins EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,087
-8.0%
|
$315,394
$62.18 P/Share
|
|
Dec 02
2020
|
David V Elkins EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,792
+12.15%
|
-
|
|
Dec 02
2020
|
Nadim Ahmed EVP and President, Hematology |
SELL
Payment of exercise price or tax liability
|
Direct |
3,380
-9.66%
|
$209,560
$62.18 P/Share
|
|
Dec 02
2020
|
Nadim Ahmed EVP and President, Hematology |
BUY
Exercise of conversion of derivative security
|
Direct |
6,594
+15.86%
|
-
|
|
Dec 02
2020
|
Rupert Vessey EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct |
4,506
-9.65%
|
$279,372
$62.18 P/Share
|
|
Dec 02
2020
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
8,792
+15.84%
|
-
|
|
Dec 01
2020
|
Joseph Eid SVP,Head Glob. Medical Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
968
-18.06%
|
$60,016
$62.41 P/Share
|
|
Dec 01
2020
|
Joseph Eid SVP,Head Glob. Medical Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
2,825
+34.52%
|
-
|
|
Nov 25
2020
|
Paul Von Autenried EVP, Chief Information Officer |
SELL
Open market or private sale
|
Direct |
3
-0.0%
|
$189
$63.5 P/Share
|
|
Nov 24
2020
|
Paul Von Autenried EVP, Chief Information Officer |
SELL
Open market or private sale
|
Direct |
20,000
-13.63%
|
$1,240,000
$62.75 P/Share
|
|
Nov 24
2020
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
SELL
Open market or private sale
|
Direct |
900
-5.59%
|
$56,700
$63.39 P/Share
|
|
Nov 23
2020
|
Rupert Vessey EVP & President, Research |
SELL
Open market or private sale
|
Direct |
13,421
-26.14%
|
$818,681
$61.34 P/Share
|
|
Nov 19
2020
|
Rupert Vessey EVP & President, Research |
SELL
Open market or private sale
|
Direct |
57,591
-33.22%
|
$3,513,051
$61.28 P/Share
|
|
Nov 19
2020
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
52,213
+11.94%
|
$2,506,224
$48.03 P/Share
|
|
Oct 30
2020
|
Rupert Vessey EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct |
2,859
-4.8%
|
$165,822
$58.45 P/Share
|
|
Oct 30
2020
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
5,804
+8.88%
|
-
|